Agios Pharmaceuticals (AGIO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 673,725 | -352,088 | -231,801 | 1,604,715 | -327,370 |
| Depreciation Amortization | -8,833 | 1,572 | 7,366 | 16,189 | 12,812 |
| Accounts receivable | -1,299 | -604 | -2,206 | N/A | N/A |
| Accounts payable and accrued liabilities | 6,601 | -8,733 | 3,436 | 1,863 | 3,330 |
| Other Working Capital | -19,768 | -19,057 | -16,433 | -36,822 | 1,965 |
| Other Operating Activity | -1,040,267 | 82,848 | -69,840 | -1,993,265 | 18,504 |
| Operating Cash Flow | $-389,841 | $-296,062 | $-309,478 | $-407,320 | $-290,759 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,645 | 326 | -3,917 | -5,741 | -14,106 |
| Purchase Of Investment | -1,542,433 | -417,930 | -1,030,781 | -1,378,221 | -557,030 |
| Sale Of Investment | 1,018,383 | 674,679 | 1,146,175 | 829,804 | 647,685 |
| Other Investing Activity | 889,136 | -17,500 | 131,784 | 1,802,936 | -803 |
| Investing Cash Flow | $363,441 | $239,575 | $243,261 | $1,248,778 | $75,746 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | 0 | -331 | -578 | -336 |
| Common Stock Issued | 14,442 | 5,433 | 2,681 | 37,296 | 11,317 |
| Common Stock Repurchased | N/A | N/A | N/A | -802,486 | N/A |
| Other Financing Activity | 0 | 0 | 0 | 0 | 250,537 |
| Financing Cash Flow | $14,442 | $5,433 | $2,350 | $-765,768 | $261,518 |
| Beginning Cash Position | 88,205 | 139,259 | 203,126 | 127,436 | 80,931 |
| End Cash Position | 76,247 | 88,205 | 139,259 | 203,126 | 127,436 |
| Net Cash Flow | $-11,958 | $-51,054 | $-63,867 | $75,690 | $46,505 |
| Free Cash Flow | |||||
| Operating Cash Flow | -389,841 | -296,062 | -309,478 | -407,320 | -290,759 |
| Capital Expenditure | -1,685 | -999 | -4,881 | -5,741 | -14,106 |
| Free Cash Flow | -391,526 | -297,061 | -314,359 | -413,061 | -304,865 |